Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1986 May;39(5):489–496. doi: 10.1136/jcp.39.5.489

Value of cytoprognostic classification in breast carcinomas.

J Mouriquand, M Gozlan-Fior, D Villemain, Y Bouchet, J C Sage, M A Mermet, M Bolla
PMCID: PMC499909  PMID: 3722403

Abstract

Two hundred and four cases of breast carcinoma were classified according to cytological features, and these were related to prognosis. A disease free interval of seven years was 95% for patients with grade I, 70% for those with grade II, and 45% for those with grade III tumours. The risk of recurrence was also related to tumour size and the presence or absence of steroid receptors in the tumour. Cytological classification of breast carcinoma based on fine needle aspiration provides valuable information concerning the prognosis of patients, which is relevant to their clinical management.

Full text

PDF
492

Images in this article

490Image
on p.490
490Image
on p.490
491Image
on p.491
491Image
on p.491

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoniades K., Spector H. Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer. Am J Clin Pathol. 1979 May;71(5):497–503. doi: 10.1093/ajcp/71.5.497. [DOI] [PubMed] [Google Scholar]
  2. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baak J. P., Kurver P. H., De Snoo-Niewlaat A. J., De Graef S., Makkink B., Boon M. E. Prognostic indicators in breast cancer--morphometric methods. Histopathology. 1982 May;6(3):327–339. doi: 10.1111/j.1365-2559.1982.tb02727.x. [DOI] [PubMed] [Google Scholar]
  4. Cheix F., Biron A., Bailly C., Mayer M., Pommatau E., Saez S. Cancer du sein opérable: valeur pronostique du nombre des récepteurs d'estradiol. Rapport préliminaire. Nouv Presse Med. 1980 Mar 15;9(13):933–935. [PubMed] [Google Scholar]
  5. Contesso G., Delarue J. C., Mouriesse H., May-Levin F., Garnier H. Anatomopathologie du cancer du sein et récepteurs hormonaux. Pathol Biol (Paris) 1983 Nov;31(9):747–754. [PubMed] [Google Scholar]
  6. Dawson P. J., Ferguson D. J., Karrison T. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy. Cancer. 1982 Nov 15;50(10):2131–2138. doi: 10.1002/1097-0142(19821115)50:10<2131::aid-cncr2820501027>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  7. Haybittle J. L., Blamey R. W., Elston C. W., Johnson J., Doyle P. J., Campbell F. C., Nicholson R. I., Griffiths K. A prognostic index in primary breast cancer. Br J Cancer. 1982 Mar;45(3):361–366. doi: 10.1038/bjc.1982.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Henderson I. C., Canellos G. P. Cancer of the breast: the past decade (first of two parts). N Engl J Med. 1980 Jan 3;302(1):17–30. doi: 10.1056/NEJM198001033020104. [DOI] [PubMed] [Google Scholar]
  9. Hilf R., Feldstein M. L., Gibson S. L., Savlov E. D. The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer. Cancer. 1980 Apr 15;45(8):1993–2000. doi: 10.1002/1097-0142(19800415)45:8<1993::aid-cncr2820450802>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  10. Hähnel R., Woodings T., Vivian A. B. Prognostic value of estrogen receptors in primary breast cancer. Cancer. 1979 Aug;44(2):671–675. doi: 10.1002/1097-0142(197908)44:2<671::aid-cncr2820440238>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  11. Knight W. A., Livingston R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed] [Google Scholar]
  12. Kuenen-Boumeester V., Hop W. C., Blonk D. I., Boon M. E. Prognostic scoring using cytomorphometry and lymph node status of patients with breast carcinoma. Eur J Cancer Clin Oncol. 1984 Mar;20(3):337–345. doi: 10.1016/0277-5379(84)90079-8. [DOI] [PubMed] [Google Scholar]
  13. MOURIQUAND J., DARGENT M. L'empreinte mammaire: étude cytopathologique. Bull Assoc Fr Etud Cancer. 1957 Dec;44(4):449–465. [PubMed] [Google Scholar]
  14. Meyer J. S., Rao B. R., Stevens S. C., White W. L. Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer. 1977 Nov;40(5):2290–2298. doi: 10.1002/1097-0142(197711)40:5<2290::aid-cncr2820400541>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  15. Mossler J. A., McCarty K. S., Jr, Woodard B. H., Mitchener L. M., Johnston W. W. Correlation of mean nuclear area with estrogen receptor content in aspiration cytology of breast carcinoma. Acta Cytol. 1982 Jul-Aug;26(4):417–421. [PubMed] [Google Scholar]
  16. Mouriquand J. "Des" colorations de Papanicolaou. Arch Anat Cytol Pathol. 1979;27(5):328–330. [PubMed] [Google Scholar]
  17. Mouriquand J., Bodin J. P., Sage J. C., Egal-Boulard V., Peralta J. L., Bouchet Y. "Cyto-pronostic" préthérapeutique du cancer du sein. 192 observations. Nouv Presse Med. 1979 Sep 24;8(36):2877–2880. [PubMed] [Google Scholar]
  18. Mouriquand J., Mouriquand C., Petitpas E., Louis J., Mermet M. A. Differential nucleolar staining affinity with a modified Papanicolaou staining procedure. Stain Technol. 1981 Jul;56(4):215–219. doi: 10.3109/10520298109067314. [DOI] [PubMed] [Google Scholar]
  19. Mouriquand J., Pasquier D. Fine needle aspiration of breast carcinoma: a preliminary cytoprognostic study. Acta Cytol. 1980 Mar-Apr;24(2):153–159. [PubMed] [Google Scholar]
  20. Pichon M. F., Pallud C., Brunet M., Milgrom E. Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res. 1980 Sep;40(9):3357–3360. [PubMed] [Google Scholar]
  21. Samaan N. A., Buzdar A. U., Aldinger K. A., Schultz P. N., Yang K. P., Romsdahl M. M., Martin R. Estrogen receptor: a prognostic factor in breast cancer. Cancer. 1981 Feb 1;47(3):554–560. doi: 10.1002/1097-0142(19810201)47:3<554::aid-cncr2820470322>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  22. Schenck U., Burger G., Jütting U., Peters-Welte C., Eiermann W. Punktionszytologie der Mamma: Korrelation visueller und bildanalytischer Untersuchungen mit dem Hormonrezeptorstatus. Geburtshilfe Frauenheilkd. 1985 Jan;45(1):17–21. doi: 10.1055/s-2008-1036199. [DOI] [PubMed] [Google Scholar]
  23. Spriggs A. I., Jerrome D. W. Intracellular mucous inclusions. A feature of malignant cells in effusions in the serous cavities, particularly due to carcinoma of the breast. J Clin Pathol. 1975 Dec;28(12):929–936. doi: 10.1136/jcp.28.12.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stenkvist B., Bengtsson E., Dahlqvist B., Eklund G., Eriksson O., Jarkrans T., Nordin B. Predicting breast cancer recurrence. Cancer. 1982 Dec 15;50(12):2884–2893. doi: 10.1002/1097-0142(19821215)50:12<2884::aid-cncr2820501231>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  25. Stewart J. F., Rubens R. D., Millis R. R., King R. J., Hayward J. L. Steroid receptors and prognosis in operable (stage I and II) breast cancer. Eur J Cancer Clin Oncol. 1983 Oct;19(10):1381–1387. doi: 10.1016/0277-5379(93)90007-r. [DOI] [PubMed] [Google Scholar]
  26. Van Bogaert L. J., Mazy G. Reliability of the cyto-radio-clinical triplet in breast pathology diagnosis. Acta Cytol. 1977 Jan-Feb;21(1):60–62. [PubMed] [Google Scholar]
  27. Verhaeghe M., Cornillot M., Herbeau J., Wurtz A., Verhaeghe G. Le triple diagnostic cyto-radio-clinique dans les tumeurs du sein (à propos de 2 460 cas) Mem Acad Chir (Paris) 1969;95(1):48–62. [PubMed] [Google Scholar]
  28. Wallgren A., Zajicek J. The prognostic value of the aspiration biopsy smear in mammary carcinoma. Acta Cytol. 1976 Sep-Oct;20(5):479–485. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES